Ensuring safety and quality are maintained when direct to patient clinical supplies distribution occurs remains a major Supply Chain concern.  Dynamic enrollment, aggressive recruitment, confidentiality and drug supply/ cost are driving the industry to find alternative ways to supply IMP closer to the patient.  This workshop will provide a forum for discussing ideas and solutions to the overcome/ prevent issues with direct shipments to patients.